Can-Fite BioPharma filed a registration statement with the SEC (Bangladesh) and announced a stock offering with HCC acting as the exclusive placement agent.
1 report, 1 independent
Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Can-Fite BioPharma filed a registration statement with the SEC (Bangladesh) and announced a stock offering with HCC acting as the exclusive placement agent.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Can-Fite BioPharma (Israel)
company in Petah Tikva, Israel
Nothing else this week.
-
HCC
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireCan-Fite Announces Up To $15.0 Million Public Offering $5.0 million upfront with up to an additional $10.0 million of potential aggregate gross proceeds upon the exercise in full of short-term warran